Next generation HIV vaccines and intradermal vaccination
HIV remains a major global public health issue, having claimed an estimated 44.1 million lives to date (1). Despite decades of research, no effective HIV vaccine exist. It is well known that the route of administration (subcutaneous, intramuscular or intradermal) can substantially modify the response. As skin tissue contains a broad array of antigen-presenting cells (APCs), intradermal vaccination is a potentially superior vaccine delivery site (2).
Learn more about:
- HIV transmission
- HIV and Cancer
- Challenges in HIV development
- Current vaccine developments
- Modern Vaccine Technologies
- Intradermal Vaccine Delivery
- VAX-ID an intradermal drug delivery that potentially solves these challenges of the currently used Mantoux technique